Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05328388 · ClinicalTrials.gov registry record · NA
A Study to Evaluate the Effect of Lycomato on Skin Attributes in Healthy Participants.
A NA study, sponsored by LycoRed.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT05328388: Completed NA study, sponsored by LycoRed.
NCT05328388 is a NA study that has completed, run by LycoRed. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05328388, a NA study, has completed, sponsored by LycoRed.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The study will be performed with oral gels, with up to 55 study subjects who meet the inclusion and non-inclusion criteria required. Study subjects will be instructed to use the products during 12 weeks and they will be assessed and supervised throughout the study by clinic technicians, in order to check for possible adverse events. Efficacy documentation through digital photography, instrumental measurements with the devices Cutometer® MPA 580 and Tewameter®, image acquisition with Visia-CA® as well as self-assessment through questionnaires will be carried out.
Primary Outcome
Visual assessments will be performed by the expert grader using a 10-point ordinal scale on the face.
Interventions
- DIETARY_SUPPLEMENT Lycomato
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-01-01 |
| Est. Completion | 2022-03-15 |
| Phase | NA |
What the finished NCT05328388 record still lists
NCT05328388 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Lycomato is the first listed.
NCT05328388 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05328388 about?
NCT05328388 is a clinical study titled "A Study to Evaluate the Effect of Lycomato on Skin Attributes in Healthy Participants.". The study will be performed with oral gels, with up to 55 study subjects who meet the inclusion and non-inclusion criteria required. Study subjects will be instructed to use the products during 12 weeks and they will be assessed and supervised throughout the study by clinic technicians, in order to ...
What is the current status of trial NCT05328388?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2022-01-01. Estimated completion is 2022-03-15.
What interventions are being tested in trial NCT05328388?
The interventions under investigation include: Lycomato (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05328388?
This trial is sponsored by LycoRed, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05328388's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI